Literature DB >> 20373515

Application of Nexus copy number software for CNV detection and analysis.

Katayoon Darvishi1.   

Abstract

Among human structural genomic variation, copy number variants (CNVs) are the most frequently known component, comprised of gains/losses of DNA segments that are generally 1 kb in length or longer. Array-based comparative genomic hybridization (aCGH) has emerged as a powerful tool for detecting genomic copy number variants (CNVs). With the rapid increase in the density of array technology and with the adaptation of new high-throughput technology, a reliable and computationally scalable method for accurate mapping of recurring DNA copy number aberrations has become a main focus in research. Here we introduce Nexus Copy Number software, a platform-independent tool, to analyze the output files of all types of commercial and custom-made comparative genomic hybridization (CGH) and single-nucleotide polymorphism (SNP) arrays, such as those manufactured by Affymetrix, Agilent Technologies, Illumina, and Roche NimbleGen. It also supports data generated by various array image-analysis software tools such as GenePix, ImaGene, and BlueFuse. (c) 2010 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20373515     DOI: 10.1002/0471142905.hg0414s65

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  14 in total

1.  An accurate and powerful method for copy number variation detection.

Authors:  Feifei Xiao; Xizhi Luo; Ning Hao; Yue S Niu; Xiangjun Xiao; Guoshuai Cai; Christopher I Amos; Heping Zhang
Journal:  Bioinformatics       Date:  2019-09-01       Impact factor: 6.937

Review 2.  Current analysis platforms and methods for detecting copy number variation.

Authors:  Wenli Li; Michael Olivier
Journal:  Physiol Genomics       Date:  2012-11-06       Impact factor: 3.107

3.  Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.

Authors:  Dane Cheasley; Marta Llaurado Fernandez; Martin Köbel; Hannah Kim; Amy Dawson; Joshua Hoenisch; Madison Bittner; Derek S Chiu; Aline Talhouk; C Blake Gilks; Madawa W Jayawardana; Kathleen I Pishas; Anne-Marie Mes-Masson; Diane Provencher; Abhimanyu Nigam; Neville F Hacker; Kylie L Gorringe; Ian G Campbell; Mark S Carey
Journal:  NPJ Precis Oncol       Date:  2022-06-29

4.  Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample.

Authors:  Guia Guffanti; Federica Torri; Jerod Rasmussen; Andrew P Clark; Anita Lakatos; Jessica A Turner; James H Fallon; Andrew J Saykin; Michael Weiner; Marquis P Vawter; James A Knowles; Steven G Potkin; Fabio Macciardi
Journal:  Genomics       Date:  2013-04-11       Impact factor: 5.736

5.  Molecular characterization of an intact p53 pathway subtype in high-grade serous ovarian cancer.

Authors:  Takahide Hayano; Yuki Yokota; Kazuyoshi Hosomichi; Hirofumi Nakaoka; Kosuke Yoshihara; Sosuke Adachi; Katsunori Kashima; Hitoshi Tsuda; Takuya Moriya; Kenichi Tanaka; Takayuki Enomoto; Ituro Inoue
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

6.  DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors.

Authors:  Richard M Bambury; Ami S Bhatt; Markus Riester; Chandra Sekhar Pedamallu; Fujiko Duke; Joaquim Bellmunt; Edward C Stack; Lillian Werner; Rachel Park; Gopa Iyer; Massimo Loda; Philip W Kantoff; Franziska Michor; Matthew Meyerson; Jonathan E Rosenberg
Journal:  BMC Cancer       Date:  2015-04-09       Impact factor: 4.430

7.  Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.

Authors:  O Hasan Ali; A A Yurchenko; O Pavlova; A Sartori; D Bomze; R Higgins; S S Ring; F Hartmann; D Bühler; F R Fritzsche; W Jochum; A A Navarini; A Kim; L E French; E Dermitzakis; A M Christiano; D Hohl; D R Bickers; S I Nikolaev; L Flatz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-23       Impact factor: 6.166

8.  Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.

Authors:  Bente A Talseth-Palmer; Elizabeth G Holliday; Tiffany-Jane Evans; Mark McEvoy; John Attia; Desma M Grice; Amy L Masson; Cliff Meldrum; Allan Spigelman; Rodney J Scott
Journal:  BMC Med Genomics       Date:  2013-03-26       Impact factor: 3.063

9.  Expanding probe repertoire and improving reproducibility in human genomic hybridization.

Authors:  Stephanie N Dorman; Ben C Shirley; Joan H M Knoll; Peter K Rogan
Journal:  Nucleic Acids Res       Date:  2013-02-01       Impact factor: 16.971

10.  Homozygous microdeletion of exon 5 in ZNF277 in a girl with specific language impairment.

Authors:  Fabiola Ceroni; Nuala H Simpson; Clyde Francks; Gillian Baird; Gina Conti-Ramsden; Ann Clark; Patrick F Bolton; Elizabeth R Hennessy; Peter Donnelly; David R Bentley; Hilary Martin; Jeremy Parr; Alistair T Pagnamenta; Elena Maestrini; Elena Bacchelli; Simon E Fisher; Dianne F Newbury
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.